trending Market Intelligence /marketintelligence/en/news-insights/trending/bwjhnyclsvumvry2gbkcxg2 content esgSubNav
In This List

Osiris Therapeutics CFO resigns; interim replacement named

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Osiris Therapeutics CFO resigns; interim replacement named

Osiris Therapeutics Inc. said Linda Chang resigned as the company's CFO.

The Columbia, Md.-based maker of regenerative medicine named Joel Rogers interim CFO.

Rogers has been Osiris Therapeutics' corporate controller since October 2017, and was previously corporate controller at industrial equipment maker ARC Group Worldwide, Inc.